Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen s Winning BioSource Bid Tops Most-Read GenomeWeb News Stories for Week Ended July 29

NEW YORK, Aug. 1 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 29.


1.  Invitrogen, Outbidding Bio-Rad, Will Buy BioSource International for $130M in Cash (from July 26)

2.  ABI's Revenues Grow 4 Percent in Q4 FY '05, Core PCR, Mass Spec Slides (from July 27)

3.  LabCorp to Validate Roche's AmpliChip, Help Evaluate Leukemia Microarray (from July 25)

4.  Two Research Firms Downgrade Beckman Coulter in Wake of Poor Earnings, Restructuring from July 25)

5.  Cepheid Finds 'Bug' in SmartCycler Diagnostic Software (from July 25)

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.